Menu
Back to Journals » Cancer Management and Research » Volume 12
Review
Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,656 | Dovepress* | 7,199+ | 1,200 | 8,399 | |
| PubMed Central* | 4,457 | 681 | 5,138 | ||
| Totals | 11,656 | 1,881 | 13,537 | ||
| *Since 17 August 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar